Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma

Vittorio Gebbia; Maria Rosaria Valerio; Hamouda Boussen

Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma

Vittorio Gebbia, Maria Rosaria Valerio, Hamouda Boussen

Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”
Discipline Chirurgiche, Oncologiche e Stomatologiche

Risultato della ricerca: Article › peer review

37 Citazioni (Scopus)

Abstract

Oral metronomic chemotherapy is a therapeutic option which is particularly attractive due to its ease of administration and low toxic burden. Its mechanism of action probably involves antiangiogenetic effect rather than a classical antiproliferative effect like standard maximally tolerated dose-based regimens.

Lingua originale	English
pagine (da-a)	529-536
Numero di pagine	8
Rivista	Anticancer Research
Volume	32
Stato di pubblicazione	Published - 2012

All Science Journal Classification (ASJC) codes

???subjectarea.asjc.2700.2730???
???subjectarea.asjc.1300.1306???

Altri file e collegamenti

OA Link

Cita questo

@article{50be5f9dbfa7443cada04d367cde6319,

title = "Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma",

abstract = "Oral metronomic chemotherapy is a therapeutic option which is particularly attractive due to its ease of administration and low toxic burden. Its mechanism of action probably involves antiangiogenetic effect rather than a classical antiproliferative effect like standard maximally tolerated dose-based regimens.",

author = "Vittorio Gebbia and Valerio, {Maria Rosaria} and Hamouda Boussen",

year = "2012",

language = "English",

volume = "32",

pages = "529--536",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

}

TY - JOUR

T1 - Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma

AU - Gebbia, Vittorio

AU - Valerio, Maria Rosaria

AU - Boussen, Hamouda

PY - 2012

Y1 - 2012

N2 - Oral metronomic chemotherapy is a therapeutic option which is particularly attractive due to its ease of administration and low toxic burden. Its mechanism of action probably involves antiangiogenetic effect rather than a classical antiproliferative effect like standard maximally tolerated dose-based regimens.

AB - Oral metronomic chemotherapy is a therapeutic option which is particularly attractive due to its ease of administration and low toxic burden. Its mechanism of action probably involves antiangiogenetic effect rather than a classical antiproliferative effect like standard maximally tolerated dose-based regimens.

UR - http://hdl.handle.net/10447/114221

M3 - Article

SN - 0250-7005

VL - 32

SP - 529

EP - 536

JO - Anticancer Research

JF - Anticancer Research

ER -

Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma

Abstract

All Science Journal Classification (ASJC) codes

Altri file e collegamenti

Fingerprint

Cita questo